Annals of the New York Academy of Sciences

Cover image for Annals of the New York Academy of Sciences

December 1984

Volume 432 Clinical Pharmacology of Cardiac Antiarrhythmic Agents: Classical and Current Concepts

Pages 1–321

  1. Part I. Theoretical and Experimental Basis of Clinical Pharmacology

    1. Top of page
    2. Part I. Theoretical and Experimental Basis of Clinical Pharmacology
    3. Part II. Clinical Conslderatlons in he Use of Cardiac Antiarrhyythmic Drugs
    4. Part III. Critical Evaluation of Methods and Techniques Used to Evaluate Drug Efficacy
    5. Part IV. The Electrophysiology, Pharmacology, and Clinical Efficacy of Claslc Cardiac Antiarrhythmic Agents
    6. Part V. Experimental Cardiac Antiarrhythmic Drugs with Unique Qualities and Therapeutic Promise
    7. Part VI. Pharhlacologlc Management of Patients with Ventricular Arrhythmias
    8. Part VII. Pharmacologic Management of Supraventricular Arrhythmias
    9. Part VIII. The Human Factor in Clinical Pharmacology: Interactions between Government and Industry, Patients and Doctors, Minds and Bodies
    1. Cellular Electrophysiologic Mechanisms of Cardiac Arrhythmias (pages 1–16)

      ANDREW L. WIT

      Article first published online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1984.tb14503.x

    2. Demonstration of the Mechanisms for Arrhythmias in Experimental Animals (pages 17–30)

      BRIAN F. HOFFMAN and KENNETH H. DANGMAN

      Article first published online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1984.tb14505.x

    3. The Cellular Mechanisms of Cardiac Antiarrhythmic Drug Action (pages 31–44)

      OFER BINAH and MICHAEL R. ROSEN

      Article first published online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1984.tb14506.x

    4. Metabolism and Excretion of Antiarrhythmic Drugs (pages 57–68)

      P. A. ROUTLEDGE

      Article first published online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1984.tb14508.x

  2. Part II. Clinical Conslderatlons in he Use of Cardiac Antiarrhyythmic Drugs

    1. Top of page
    2. Part I. Theoretical and Experimental Basis of Clinical Pharmacology
    3. Part II. Clinical Conslderatlons in he Use of Cardiac Antiarrhyythmic Drugs
    4. Part III. Critical Evaluation of Methods and Techniques Used to Evaluate Drug Efficacy
    5. Part IV. The Electrophysiology, Pharmacology, and Clinical Efficacy of Claslc Cardiac Antiarrhythmic Agents
    6. Part V. Experimental Cardiac Antiarrhythmic Drugs with Unique Qualities and Therapeutic Promise
    7. Part VI. Pharhlacologlc Management of Patients with Ventricular Arrhythmias
    8. Part VII. Pharmacologic Management of Supraventricular Arrhythmias
    9. Part VIII. The Human Factor in Clinical Pharmacology: Interactions between Government and Industry, Patients and Doctors, Minds and Bodies
    1. The Pharmacogenetics of Antiarrhythmic Drugs (pages 69–74)

      MARCUS M. REIDENBERG

      Article first published online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1984.tb14509.x

    2. Metabolites of Cardiac Antiarrhythmic Drugs: Their Clinical Role (pages 75–89)

      ROBERT E. KATES

      Article first published online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1984.tb14510.x

  3. Part III. Critical Evaluation of Methods and Techniques Used to Evaluate Drug Efficacy

    1. Top of page
    2. Part I. Theoretical and Experimental Basis of Clinical Pharmacology
    3. Part II. Clinical Conslderatlons in he Use of Cardiac Antiarrhyythmic Drugs
    4. Part III. Critical Evaluation of Methods and Techniques Used to Evaluate Drug Efficacy
    5. Part IV. The Electrophysiology, Pharmacology, and Clinical Efficacy of Claslc Cardiac Antiarrhythmic Agents
    6. Part V. Experimental Cardiac Antiarrhythmic Drugs with Unique Qualities and Therapeutic Promise
    7. Part VI. Pharhlacologlc Management of Patients with Ventricular Arrhythmias
    8. Part VII. Pharmacologic Management of Supraventricular Arrhythmias
    9. Part VIII. The Human Factor in Clinical Pharmacology: Interactions between Government and Industry, Patients and Doctors, Minds and Bodies
    1. Technological Status and Problems of Ambulatory Electrocardiographic Monitoring (pages 108–116)

      ROGER A. WINKLE, INEZ RODRIGUEZ and DEBORAH A. BRAGG-REMSCHEL

      Article first published online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1984.tb14513.x

    2. Therapeutic Drug Monitoring Techniques: An Overview (pages 129–137)

      C. E. PIPPENGER

      Article first published online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1984.tb14515.x

    3. Monitoring of Antiarrhythmic Drug Levels: Values and Pitfalls (pages 138–154)

      JOEL KUPERSMITH

      Article first published online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1984.tb14516.x

    4. Invasive Electrophysiologic Testing: A Critical Appraisal (pages 155–161)

      MELVIN M. SCHEINMAN, FRED MORADY and EDWARD N. SHEN

      Article first published online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1984.tb14517.x

  4. Part IV. The Electrophysiology, Pharmacology, and Clinical Efficacy of Claslc Cardiac Antiarrhythmic Agents

    1. Top of page
    2. Part I. Theoretical and Experimental Basis of Clinical Pharmacology
    3. Part II. Clinical Conslderatlons in he Use of Cardiac Antiarrhyythmic Drugs
    4. Part III. Critical Evaluation of Methods and Techniques Used to Evaluate Drug Efficacy
    5. Part IV. The Electrophysiology, Pharmacology, and Clinical Efficacy of Claslc Cardiac Antiarrhythmic Agents
    6. Part V. Experimental Cardiac Antiarrhythmic Drugs with Unique Qualities and Therapeutic Promise
    7. Part VI. Pharhlacologlc Management of Patients with Ventricular Arrhythmias
    8. Part VII. Pharmacologic Management of Supraventricular Arrhythmias
    9. Part VIII. The Human Factor in Clinical Pharmacology: Interactions between Government and Industry, Patients and Doctors, Minds and Bodies
    1. Quinidine (pages 162–176)

      JAY W. MASON and LUC M. HONDEGHEM

      Article first published online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1984.tb14518.x

    2. Procainamide: Clinical Pharmacology and Efficacy against Ventricular Arrhythmias (pages 177–188)

      ELSA-GRACE V. GIARDINA

      Article first published online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1984.tb14519.x

    3. Disopyramide (pages 189–200)

      E. M. VAUGHAN WILLIAMS

      Article first published online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1984.tb14520.x

  5. Part V. Experimental Cardiac Antiarrhythmic Drugs with Unique Qualities and Therapeutic Promise

    1. Top of page
    2. Part I. Theoretical and Experimental Basis of Clinical Pharmacology
    3. Part II. Clinical Conslderatlons in he Use of Cardiac Antiarrhyythmic Drugs
    4. Part III. Critical Evaluation of Methods and Techniques Used to Evaluate Drug Efficacy
    5. Part IV. The Electrophysiology, Pharmacology, and Clinical Efficacy of Claslc Cardiac Antiarrhythmic Agents
    6. Part V. Experimental Cardiac Antiarrhythmic Drugs with Unique Qualities and Therapeutic Promise
    7. Part VI. Pharhlacologlc Management of Patients with Ventricular Arrhythmias
    8. Part VII. Pharmacologic Management of Supraventricular Arrhythmias
    9. Part VIII. The Human Factor in Clinical Pharmacology: Interactions between Government and Industry, Patients and Doctors, Minds and Bodies
    1. Electrophysiology and Pharmacology of Aprindine, Encainide, and Propafenone (pages 201–209)

      DOUGLAS P. ZIPES, ERIC N. PRYSTOWSKY and JAMES J. HEGER

      Article first published online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1984.tb14521.x

    2. The Electrophysiology and Pharmacology of Verapamil, Flecainide, and Amiodarone: Correlations with Clinical Effects and Antiarrhythmic Actions (pages 210–235)

      BRAMAH N. SINGH M.D., KOONLAWEE NADEMANEE, MARTIN A. JOSEPHSON, NOBUO IKEDA, NAGAMMAL VENKATESH and RAMASWAMY KANNAN

      Article first published online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1984.tb14522.x

  6. Part VI. Pharhlacologlc Management of Patients with Ventricular Arrhythmias

    1. Top of page
    2. Part I. Theoretical and Experimental Basis of Clinical Pharmacology
    3. Part II. Clinical Conslderatlons in he Use of Cardiac Antiarrhyythmic Drugs
    4. Part III. Critical Evaluation of Methods and Techniques Used to Evaluate Drug Efficacy
    5. Part IV. The Electrophysiology, Pharmacology, and Clinical Efficacy of Claslc Cardiac Antiarrhythmic Agents
    6. Part V. Experimental Cardiac Antiarrhythmic Drugs with Unique Qualities and Therapeutic Promise
    7. Part VI. Pharhlacologlc Management of Patients with Ventricular Arrhythmias
    8. Part VII. Pharmacologic Management of Supraventricular Arrhythmias
    9. Part VIII. The Human Factor in Clinical Pharmacology: Interactions between Government and Industry, Patients and Doctors, Minds and Bodies
    1. Considerations in the Long-Term Management of Survivors of Cardiac Arrest (pages 247–257)

      LEONARD A. COBB, ALFRED P. HALLSTROM, W. DOUGLAS WEAVER, GENE B. TROBAUGH and H. LEON GREENE

      Article first published online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1984.tb14524.x

  7. Part VII. Pharmacologic Management of Supraventricular Arrhythmias

    1. Top of page
    2. Part I. Theoretical and Experimental Basis of Clinical Pharmacology
    3. Part II. Clinical Conslderatlons in he Use of Cardiac Antiarrhyythmic Drugs
    4. Part III. Critical Evaluation of Methods and Techniques Used to Evaluate Drug Efficacy
    5. Part IV. The Electrophysiology, Pharmacology, and Clinical Efficacy of Claslc Cardiac Antiarrhythmic Agents
    6. Part V. Experimental Cardiac Antiarrhythmic Drugs with Unique Qualities and Therapeutic Promise
    7. Part VI. Pharhlacologlc Management of Patients with Ventricular Arrhythmias
    8. Part VII. Pharmacologic Management of Supraventricular Arrhythmias
    9. Part VIII. The Human Factor in Clinical Pharmacology: Interactions between Government and Industry, Patients and Doctors, Minds and Bodies
    1. Atrial Flutter and Atrial Fibrillation: Drug Therapy and Recent Observations (pages 258–271)

      ALBERT L. WALDO, RICHARD W. HENTHORN and VANCE J. PLUMB

      Article first published online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1984.tb14525.x

    2. Drug Therapy of Patients with Arrhythmias Associated with Bypass Tracts (pages 272–278)

      HEIN J. J. WELLENS, PEDRO BRUGADA and HOSHIAR ABDOLLAH

      Article first published online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1984.tb14526.x

  8. Part VIII. The Human Factor in Clinical Pharmacology: Interactions between Government and Industry, Patients and Doctors, Minds and Bodies

    1. Top of page
    2. Part I. Theoretical and Experimental Basis of Clinical Pharmacology
    3. Part II. Clinical Conslderatlons in he Use of Cardiac Antiarrhyythmic Drugs
    4. Part III. Critical Evaluation of Methods and Techniques Used to Evaluate Drug Efficacy
    5. Part IV. The Electrophysiology, Pharmacology, and Clinical Efficacy of Claslc Cardiac Antiarrhythmic Agents
    6. Part V. Experimental Cardiac Antiarrhythmic Drugs with Unique Qualities and Therapeutic Promise
    7. Part VI. Pharhlacologlc Management of Patients with Ventricular Arrhythmias
    8. Part VII. Pharmacologic Management of Supraventricular Arrhythmias
    9. Part VIII. The Human Factor in Clinical Pharmacology: Interactions between Government and Industry, Patients and Doctors, Minds and Bodies
    1. Drug Development: Risks and Problems (pages 279–286)

      DANIEL L. AZARNOFF and ROBERT L. HERTING

      Article first published online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1984.tb14527.x

    2. Antiarrhythmic Therapy: The Issue of Patient Compliance (pages 286–295)

      CAROLYN SOMELOFSKI and ROBERT W. PETERS

      Article first published online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1984.tb14528.x

    3. Future Perspectives in Antiarrhythmic Drugs (pages 314–321)

      DONALD C. HARRISON

      Article first published online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1984.tb14530.x

SEARCH

SEARCH BY CITATION